retatrutide weight loss clinical data 💉 may be redefining obesity treatment. New from TRIUMPH-1 Trial showed: 🔥 ~28% average over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide, an experimental weight-loss drug,

But heres a pro tip from our labs: for long-term storage of lyophilized powder (meaning you don't plan to use it for several months), a freezer is even better

The Food and Drug Administration (FDA) has approved Eli Lillys once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problems

While still more pronounced than pre weight loss, my nasolabial folds were definitely not as deep, while my jawline looked in better nick too

Identification of novel therapeutic targets

The main question has changed from whether Novo Nordisks growth will continue with obesity treatments to how well the business can scale up manufacturing to meet rising worldwide demand in a market that is becoming more competitive